Cadrenal Therapeutics, Inc. (CVKD)

Cadrenal Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	2.39	4.01	10.02	8.4	0.03
Cash & Short-Term Investments	2.39	4.01	10.02	8.4	0.03
Cash Growth	-57.13%	-59.99%	19.23%	25685.61%	-
Other Receivables	2.69	0.01	0.04	0.04	-
Receivables	2.69	0.01	0.04	0.04	-
Prepaid Expenses	0.41	0.2	0.04	0.05	0.02
Other Current Assets	0.1	0.11	0.01	-	0.67
Total Current Assets	5.58	4.32	10.11	8.49	0.73
Property, Plant & Equipment	0	0.01	0.01	0.02	0.04
Other Long-Term Assets	0	0	0	0	0.01
Total Assets	5.59	4.33	10.12	8.52	0.78

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Accounts Payable	0.87	0.65	1.5	0.17	0.4
Accrued Expenses	0.63	0.94	1.18	0.64	0.86
Short-Term Debt	-	-	-	-	0.04
Current Portion of Leases	-	-	-	0.02	0.02
Total Current Liabilities	1.5	1.59	2.68	0.83	1.33
Long-Term Debt	-	-	-	-	0.55
Long-Term Leases	-	-	-	-	0.02
Other Long-Term Liabilities	-	-	-	-	4.42
Total Liabilities	1.5	1.59	2.68	0.83	6.33

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Common Stock	0	0	0	0	0.01
Additional Paid-In Capital	48.87	41.7	33.16	22.76	1.15
Retained Earnings	-44.78	-38.96	-25.72	-15.07	-6.71
Shareholders' Equity	4.09	2.74	7.44	7.69	-5.55
Total Liabilities & Equity	5.59	4.33	10.12	8.52	0.78

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Total Debt	-	-	-	0.02	0.64
Net Cash (Debt)	2.39	4.01	10.02	8.38	-0.61
Net Cash Growth	-57.13%	-59.99%	19.53%	-	-
Net Cash Per Share	1.01	2.01	8.21	9.32	-1.16
Filing Date Shares Outstanding	3.57	2.51	1.88	1.07	0.78
Total Common Shares Outstanding	3.1	2.34	1.78	0.87	0.55
Working Capital	4.09	2.73	7.43	7.67	-0.61
Book Value Per Share	1.32	1.17	4.17	8.86	-10.16
Tangible Book Value	4.09	2.74	7.44	7.69	-5.55
Tangible Book Value Per Share	1.32	1.17	4.17	8.86	-10.16

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 9, 2026

Data Sources Report a data error